On Tuesday, Annovis Bio Inc (NYSE: ANVS) was 8.89% up from the session before settling in for the closing price of $1.35. A 52-week range for ANVS has been $1.11 – $20.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 23.23%. With a float of $16.67 million, this company’s outstanding shares have now reached $19.49 million.
Let’s determine the extent of company efficiency that accounts for 8 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Annovis Bio Inc (ANVS) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Annovis Bio Inc stocks. The insider ownership of Annovis Bio Inc is 14.45%, while institutional ownership is 13.22%.
Annovis Bio Inc (ANVS) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.23% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.23% during the next five years compared to -73.95% drop over the previous five years of trading.
Annovis Bio Inc (NYSE: ANVS) Trading Performance Indicators
You can see what Annovis Bio Inc (ANVS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.00, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.67 in one year’s time.
Technical Analysis of Annovis Bio Inc (ANVS)
Looking closely at Annovis Bio Inc (NYSE: ANVS), its last 5-days average volume was 0.96 million, which is a jump from its year-to-date volume of 0.5 million. As of the previous 9 days, the stock’s Stochastic %D was 46.07%. Additionally, its Average True Range was 0.18.
During the past 100 days, Annovis Bio Inc’s (ANVS) raw stochastic average was set at 5.62%, which indicates a significant decrease from 60.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 97.51% in the past 14 days, which was lower than the 104.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7562, while its 200-day Moving Average is $6.2186. However, in the short run, Annovis Bio Inc’s stock first resistance to watch stands at $1.5733. Second resistance stands at $1.6767. The third major resistance level sits at $1.7633. If the price goes on to break the first support level at $1.3833, it is likely to go to the next support level at $1.2967. Now, if the price goes above the second support level, the third support stands at $1.1933.
Annovis Bio Inc (NYSE: ANVS) Key Stats
There are 14,236K outstanding shares of the company, which has a market capitalization of 28.65 million. As of now, sales total 0 K while income totals -24,590 K. Its latest quarter income was 0 K while its last quarter net income were -5,860 K.
